| Dr Michelle Borowski, DO | |
|
816 Kearny Ave, Kearny, NJ 07032-3148 | |
| (201) 991-4544 | |
| (201) 991-8524 |
| Full Name | Dr Michelle Borowski |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 816 Kearny Ave, Kearny, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902027790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 25MB08229700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Borowski, DO 816 Kearny Ave, Kearny, NJ 07032-3148 Ph: (201) 991-4544 | Dr Michelle Borowski, DO 816 Kearny Ave, Kearny, NJ 07032-3148 Ph: (201) 991-4544 |
News Archive
Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.
Seth Field, MD, PhD, associate professor in the Department of Medicine at UC San Diego, has been awarded a five-year, $3.86 million "Era of Hope Scholar Award" from the Department of Defense Breast Cancer Research Program. The award supports individuals who have high potential for innovation in breast cancer research early in their careers, researchers considered the "best and brightest" in their field through "extraordinary creativity, vision and productivity and potential for leadership in the breast cancer research community.
Stem cells, delivered intranasally, were found to substantially improve motor function in Parkinson's disease in a study co-authored by William H. Frey II, Ph.D, Director of the Alzheimer's Research Center, part of HealthPartners Research Foundation. Frey collaborated with Lusine Danielyan, MD, of University Hospital of Tubingen in Germany.
Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.
CTI BioPharma Corp. today announced data showing treatment with pacritinib, an investigational oral multikinase inhibitor in Phase 3 clinical development, preferentially killed acute myeloid leukemia (AML) cells with FLT3 mutations, overcame stromal protection and suppressed leukemic outgrowth from stroma adherent AML cells in both medium-term (7-14 days) and long-term (5-6 weeks) assays.
› Verified 2 days ago
Dr. Mohan Sakharam Deshpande, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 806 Kearny Ave, Kearny, NJ 07032 Phone: 201-997-8806 | |
Jehad E Saliba, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 744 Kearny Ave, Kearny, NJ 07032 Phone: 201-991-4544 Fax: 201-991-8524 | |
Salvatore Michael Rifici, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 416 Kearny Avenue, Kearny, NJ 07032 Phone: 201-997-4000 Fax: 201-997-3345 | |
Dr. Mudassar Sharif, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 711 Kearny Ave, Kearny, NJ 07032 Phone: 888-412-6606 Fax: 888-412-6606 | |
Viren Desai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 221 Kearny Ave, Kearny, NJ 07032 Phone: 201-997-0808 Fax: 201-997-0013 | |
Prakash J Doshi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 206 Bergen Ave, Suite # 201, Kearny, NJ 07032 Phone: 201-998-7474 |